nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—Tinnitus—Pravastatin—atherosclerosis	0.00109	0.00116	CcSEcCtD
Gabapentin—Malaise—Lovastatin—atherosclerosis	0.00108	0.00116	CcSEcCtD
Gabapentin—Cardiac disorder—Pravastatin—atherosclerosis	0.00108	0.00116	CcSEcCtD
Gabapentin—Muscle spasms—Simvastatin—atherosclerosis	0.00108	0.00115	CcSEcCtD
Gabapentin—Vertigo—Lovastatin—atherosclerosis	0.00108	0.00115	CcSEcCtD
Gabapentin—Angioedema—Ezetimibe—atherosclerosis	0.00108	0.00115	CcSEcCtD
Gabapentin—Leukopenia—Lovastatin—atherosclerosis	0.00108	0.00115	CcSEcCtD
Gabapentin—Chills—Niacin—atherosclerosis	0.00106	0.00114	CcSEcCtD
Gabapentin—Malaise—Ezetimibe—atherosclerosis	0.00106	0.00113	CcSEcCtD
Gabapentin—Vision blurred—Simvastatin—atherosclerosis	0.00106	0.00113	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00106	0.00113	CcSEcCtD
Gabapentin—Tremor—Simvastatin—atherosclerosis	0.00105	0.00112	CcSEcCtD
Gabapentin—Alopecia—Niacin—atherosclerosis	0.00105	0.00112	CcSEcCtD
Gabapentin—Chills—Pravastatin—atherosclerosis	0.00105	0.00112	CcSEcCtD
Gabapentin—Insomnia—Rosuvastatin—atherosclerosis	0.00105	0.00112	CcSEcCtD
Gabapentin—Ill-defined disorder—Simvastatin—atherosclerosis	0.00104	0.00111	CcSEcCtD
Gabapentin—Palpitations—Ezetimibe—atherosclerosis	0.00104	0.00111	CcSEcCtD
Gabapentin—Paraesthesia—Rosuvastatin—atherosclerosis	0.00104	0.00111	CcSEcCtD
Gabapentin—Anaemia—Simvastatin—atherosclerosis	0.00104	0.00111	CcSEcCtD
Gabapentin—Erythema—Niacin—atherosclerosis	0.00103	0.0011	CcSEcCtD
Gabapentin—Malnutrition—Niacin—atherosclerosis	0.00103	0.0011	CcSEcCtD
Gabapentin—Alopecia—Pravastatin—atherosclerosis	0.00103	0.0011	CcSEcCtD
Gabapentin—Cough—Ezetimibe—atherosclerosis	0.00103	0.0011	CcSEcCtD
Gabapentin—Angioedema—Simvastatin—atherosclerosis	0.00103	0.0011	CcSEcCtD
Gabapentin—Chest pain—Lovastatin—atherosclerosis	0.00102	0.00109	CcSEcCtD
Gabapentin—Arthralgia—Lovastatin—atherosclerosis	0.00102	0.00109	CcSEcCtD
Gabapentin—Myalgia—Lovastatin—atherosclerosis	0.00102	0.00109	CcSEcCtD
Gabapentin—Anxiety—Lovastatin—atherosclerosis	0.00102	0.00109	CcSEcCtD
Gabapentin—Dyspepsia—Rosuvastatin—atherosclerosis	0.00102	0.00109	CcSEcCtD
Gabapentin—Hypertension—Ezetimibe—atherosclerosis	0.00102	0.00109	CcSEcCtD
Gabapentin—Flatulence—Niacin—atherosclerosis	0.00102	0.00109	CcSEcCtD
Gabapentin—Malaise—Simvastatin—atherosclerosis	0.00101	0.00108	CcSEcCtD
Gabapentin—Tension—Niacin—atherosclerosis	0.00101	0.00108	CcSEcCtD
Gabapentin—Discomfort—Lovastatin—atherosclerosis	0.00101	0.00108	CcSEcCtD
Gabapentin—Vertigo—Simvastatin—atherosclerosis	0.00101	0.00108	CcSEcCtD
Gabapentin—Leukopenia—Simvastatin—atherosclerosis	0.00101	0.00107	CcSEcCtD
Gabapentin—Arthralgia—Ezetimibe—atherosclerosis	0.001	0.00107	CcSEcCtD
Gabapentin—Chest pain—Ezetimibe—atherosclerosis	0.001	0.00107	CcSEcCtD
Gabapentin—Myalgia—Ezetimibe—atherosclerosis	0.001	0.00107	CcSEcCtD
Gabapentin—Nervousness—Niacin—atherosclerosis	0.001	0.00107	CcSEcCtD
Gabapentin—Flatulence—Pravastatin—atherosclerosis	0.001	0.00107	CcSEcCtD
Gabapentin—Dry mouth—Lovastatin—atherosclerosis	0.001	0.00107	CcSEcCtD
Gabapentin—Tension—Pravastatin—atherosclerosis	0.000998	0.00106	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000998	0.00106	CcSEcCtD
Gabapentin—Dysgeusia—Pravastatin—atherosclerosis	0.000996	0.00106	CcSEcCtD
Gabapentin—Muscle spasms—Niacin—atherosclerosis	0.000993	0.00106	CcSEcCtD
Gabapentin—Discomfort—Ezetimibe—atherosclerosis	0.000992	0.00106	CcSEcCtD
Gabapentin—Pain—Rosuvastatin—atherosclerosis	0.000991	0.00106	CcSEcCtD
Gabapentin—Constipation—Rosuvastatin—atherosclerosis	0.000991	0.00106	CcSEcCtD
Gabapentin—Confusional state—Lovastatin—atherosclerosis	0.00099	0.00106	CcSEcCtD
Gabapentin—Nervousness—Pravastatin—atherosclerosis	0.000988	0.00105	CcSEcCtD
Gabapentin—Dry mouth—Ezetimibe—atherosclerosis	0.000982	0.00105	CcSEcCtD
Gabapentin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000982	0.00105	CcSEcCtD
Gabapentin—Muscle spasms—Pravastatin—atherosclerosis	0.000978	0.00104	CcSEcCtD
Gabapentin—Infection—Lovastatin—atherosclerosis	0.000975	0.00104	CcSEcCtD
Gabapentin—Vision blurred—Niacin—atherosclerosis	0.000974	0.00104	CcSEcCtD
Gabapentin—Confusional state—Ezetimibe—atherosclerosis	0.000971	0.00103	CcSEcCtD
Gabapentin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000963	0.00103	CcSEcCtD
Gabapentin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000961	0.00102	CcSEcCtD
Gabapentin—Vision blurred—Pravastatin—atherosclerosis	0.000959	0.00102	CcSEcCtD
Gabapentin—Chest pain—Simvastatin—atherosclerosis	0.000958	0.00102	CcSEcCtD
Gabapentin—Arthralgia—Simvastatin—atherosclerosis	0.000958	0.00102	CcSEcCtD
Gabapentin—Myalgia—Simvastatin—atherosclerosis	0.000958	0.00102	CcSEcCtD
Gabapentin—Infection—Ezetimibe—atherosclerosis	0.000957	0.00102	CcSEcCtD
Gabapentin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000955	0.00102	CcSEcCtD
Gabapentin—Anxiety—Simvastatin—atherosclerosis	0.000955	0.00102	CcSEcCtD
Gabapentin—Tremor—Pravastatin—atherosclerosis	0.000953	0.00102	CcSEcCtD
Gabapentin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000947	0.00101	CcSEcCtD
Gabapentin—Discomfort—Simvastatin—atherosclerosis	0.000946	0.00101	CcSEcCtD
Gabapentin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000944	0.00101	CcSEcCtD
Gabapentin—Angioedema—Niacin—atherosclerosis	0.000944	0.00101	CcSEcCtD
Gabapentin—Ill-defined disorder—Pravastatin—atherosclerosis	0.000944	0.00101	CcSEcCtD
Gabapentin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000943	0.001	CcSEcCtD
Gabapentin—Anaemia—Pravastatin—atherosclerosis	0.00094	0.001	CcSEcCtD
Gabapentin—Anorexia—Lovastatin—atherosclerosis	0.000936	0.000998	CcSEcCtD
Gabapentin—Skin disorder—Ezetimibe—atherosclerosis	0.000935	0.000997	CcSEcCtD
Gabapentin—Angioedema—Pravastatin—atherosclerosis	0.00093	0.000991	CcSEcCtD
Gabapentin—Vertigo—Niacin—atherosclerosis	0.000928	0.000989	CcSEcCtD
Gabapentin—Syncope—Niacin—atherosclerosis	0.000927	0.000988	CcSEcCtD
Gabapentin—Confusional state—Simvastatin—atherosclerosis	0.000926	0.000987	CcSEcCtD
Gabapentin—Leukopenia—Niacin—atherosclerosis	0.000925	0.000986	CcSEcCtD
Gabapentin—Urticaria—Rosuvastatin—atherosclerosis	0.00092	0.000981	CcSEcCtD
Gabapentin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000918	0.000979	CcSEcCtD
Gabapentin—Oedema—Simvastatin—atherosclerosis	0.000918	0.000979	CcSEcCtD
Gabapentin—Malaise—Pravastatin—atherosclerosis	0.000917	0.000978	CcSEcCtD
Gabapentin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000916	0.000976	CcSEcCtD
Gabapentin—Vertigo—Pravastatin—atherosclerosis	0.000914	0.000974	CcSEcCtD
Gabapentin—Palpitations—Niacin—atherosclerosis	0.000913	0.000973	CcSEcCtD
Gabapentin—Infection—Simvastatin—atherosclerosis	0.000912	0.000972	CcSEcCtD
Gabapentin—Leukopenia—Pravastatin—atherosclerosis	0.000911	0.000971	CcSEcCtD
Gabapentin—Loss of consciousness—Niacin—atherosclerosis	0.000908	0.000968	CcSEcCtD
Gabapentin—Cough—Niacin—atherosclerosis	0.000902	0.000961	CcSEcCtD
Gabapentin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000899	0.000958	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000894	0.000953	CcSEcCtD
Gabapentin—Insomnia—Lovastatin—atherosclerosis	0.000888	0.000947	CcSEcCtD
Gabapentin—Cough—Pravastatin—atherosclerosis	0.000888	0.000946	CcSEcCtD
Gabapentin—Paraesthesia—Lovastatin—atherosclerosis	0.000882	0.00094	CcSEcCtD
Gabapentin—Myalgia—Niacin—atherosclerosis	0.00088	0.000938	CcSEcCtD
Gabapentin—Arthralgia—Niacin—atherosclerosis	0.00088	0.000938	CcSEcCtD
Gabapentin—Hypertension—Pravastatin—atherosclerosis	0.000878	0.000936	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000877	0.000935	CcSEcCtD
Gabapentin—Anorexia—Simvastatin—atherosclerosis	0.000875	0.000933	CcSEcCtD
Gabapentin—Dyspnoea—Lovastatin—atherosclerosis	0.000875	0.000933	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000874	0.000931	CcSEcCtD
Gabapentin—Insomnia—Ezetimibe—atherosclerosis	0.000871	0.000928	CcSEcCtD
Gabapentin—Arthralgia—Pravastatin—atherosclerosis	0.000866	0.000923	CcSEcCtD
Gabapentin—Chest pain—Pravastatin—atherosclerosis	0.000866	0.000923	CcSEcCtD
Gabapentin—Myalgia—Pravastatin—atherosclerosis	0.000866	0.000923	CcSEcCtD
Gabapentin—Paraesthesia—Ezetimibe—atherosclerosis	0.000865	0.000922	CcSEcCtD
Gabapentin—Dyspepsia—Lovastatin—atherosclerosis	0.000864	0.000921	CcSEcCtD
Gabapentin—Anxiety—Pravastatin—atherosclerosis	0.000863	0.00092	CcSEcCtD
Gabapentin—Dry mouth—Niacin—atherosclerosis	0.00086	0.000917	CcSEcCtD
Gabapentin—Dyspnoea—Ezetimibe—atherosclerosis	0.000859	0.000915	CcSEcCtD
Gabapentin—Discomfort—Pravastatin—atherosclerosis	0.000856	0.000912	CcSEcCtD
Gabapentin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000854	0.00091	CcSEcCtD
Gabapentin—Decreased appetite—Lovastatin—atherosclerosis	0.000853	0.00091	CcSEcCtD
Gabapentin—Dyspepsia—Ezetimibe—atherosclerosis	0.000848	0.000904	CcSEcCtD
Gabapentin—Fatigue—Lovastatin—atherosclerosis	0.000846	0.000902	CcSEcCtD
Gabapentin—Oedema—Niacin—atherosclerosis	0.000843	0.000899	CcSEcCtD
Gabapentin—Anaphylactic shock—Niacin—atherosclerosis	0.000843	0.000899	CcSEcCtD
Gabapentin—Pain—Lovastatin—atherosclerosis	0.00084	0.000895	CcSEcCtD
Gabapentin—Constipation—Lovastatin—atherosclerosis	0.00084	0.000895	CcSEcCtD
Gabapentin—Confusional state—Pravastatin—atherosclerosis	0.000837	0.000892	CcSEcCtD
Gabapentin—Decreased appetite—Ezetimibe—atherosclerosis	0.000837	0.000892	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000837	0.000892	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000831	0.000886	CcSEcCtD
Gabapentin—Asthenia—Rosuvastatin—atherosclerosis	0.000831	0.000886	CcSEcCtD
Gabapentin—Insomnia—Simvastatin—atherosclerosis	0.000831	0.000885	CcSEcCtD
Gabapentin—Oedema—Pravastatin—atherosclerosis	0.00083	0.000885	CcSEcCtD
Gabapentin—Anaphylactic shock—Pravastatin—atherosclerosis	0.00083	0.000885	CcSEcCtD
Gabapentin—Fatigue—Ezetimibe—atherosclerosis	0.00083	0.000885	CcSEcCtD
Gabapentin—Shock—Niacin—atherosclerosis	0.00083	0.000884	CcSEcCtD
Gabapentin—Infection—Pravastatin—atherosclerosis	0.000825	0.000879	CcSEcCtD
Gabapentin—Paraesthesia—Simvastatin—atherosclerosis	0.000825	0.000879	CcSEcCtD
Gabapentin—Pain—Ezetimibe—atherosclerosis	0.000823	0.000878	CcSEcCtD
Gabapentin—Constipation—Ezetimibe—atherosclerosis	0.000823	0.000878	CcSEcCtD
Gabapentin—Tachycardia—Niacin—atherosclerosis	0.000823	0.000877	CcSEcCtD
Gabapentin—Pruritus—Rosuvastatin—atherosclerosis	0.00082	0.000874	CcSEcCtD
Gabapentin—Skin disorder—Niacin—atherosclerosis	0.000819	0.000873	CcSEcCtD
Gabapentin—Dyspnoea—Simvastatin—atherosclerosis	0.000819	0.000873	CcSEcCtD
Gabapentin—Hyperhidrosis—Niacin—atherosclerosis	0.000815	0.000869	CcSEcCtD
Gabapentin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000813	0.000866	CcSEcCtD
Gabapentin—Feeling abnormal—Lovastatin—atherosclerosis	0.000809	0.000862	CcSEcCtD
Gabapentin—Dyspepsia—Simvastatin—atherosclerosis	0.000808	0.000862	CcSEcCtD
Gabapentin—Anorexia—Niacin—atherosclerosis	0.000804	0.000857	CcSEcCtD
Gabapentin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000803	0.000856	CcSEcCtD
Gabapentin—Hyperhidrosis—Pravastatin—atherosclerosis	0.000803	0.000856	CcSEcCtD
Gabapentin—Decreased appetite—Simvastatin—atherosclerosis	0.000798	0.000851	CcSEcCtD
Gabapentin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000794	0.000846	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000793	0.000845	CcSEcCtD
Gabapentin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000793	0.000845	CcSEcCtD
Gabapentin—Fatigue—Simvastatin—atherosclerosis	0.000792	0.000844	CcSEcCtD
Gabapentin—Anorexia—Pravastatin—atherosclerosis	0.000791	0.000844	CcSEcCtD
Gabapentin—Hypotension—Niacin—atherosclerosis	0.000788	0.00084	CcSEcCtD
Gabapentin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000787	0.000839	CcSEcCtD
Gabapentin—Constipation—Simvastatin—atherosclerosis	0.000785	0.000837	CcSEcCtD
Gabapentin—Pain—Simvastatin—atherosclerosis	0.000785	0.000837	CcSEcCtD
Gabapentin—Urticaria—Lovastatin—atherosclerosis	0.00078	0.000831	CcSEcCtD
Gabapentin—Body temperature increased—Lovastatin—atherosclerosis	0.000776	0.000827	CcSEcCtD
Gabapentin—Abdominal pain—Lovastatin—atherosclerosis	0.000776	0.000827	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000768	0.000819	CcSEcCtD
Gabapentin—Dizziness—Rosuvastatin—atherosclerosis	0.000766	0.000817	CcSEcCtD
Gabapentin—Urticaria—Ezetimibe—atherosclerosis	0.000765	0.000815	CcSEcCtD
Gabapentin—Insomnia—Niacin—atherosclerosis	0.000763	0.000813	CcSEcCtD
Gabapentin—Abdominal pain—Ezetimibe—atherosclerosis	0.000761	0.000811	CcSEcCtD
Gabapentin—Body temperature increased—Ezetimibe—atherosclerosis	0.000761	0.000811	CcSEcCtD
Gabapentin—Paraesthesia—Niacin—atherosclerosis	0.000757	0.000807	CcSEcCtD
Gabapentin—Feeling abnormal—Simvastatin—atherosclerosis	0.000757	0.000807	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000756	0.000806	CcSEcCtD
Gabapentin—Dyspnoea—Niacin—atherosclerosis	0.000752	0.000801	CcSEcCtD
Gabapentin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000751	0.0008	CcSEcCtD
Gabapentin—Insomnia—Pravastatin—atherosclerosis	0.000751	0.0008	CcSEcCtD
Gabapentin—Somnolence—Niacin—atherosclerosis	0.00075	0.000799	CcSEcCtD
Gabapentin—Paraesthesia—Pravastatin—atherosclerosis	0.000745	0.000795	CcSEcCtD
Gabapentin—Dyspepsia—Niacin—atherosclerosis	0.000742	0.000791	CcSEcCtD
Gabapentin—Dyspnoea—Pravastatin—atherosclerosis	0.00074	0.000789	CcSEcCtD
Gabapentin—Decreased appetite—Niacin—atherosclerosis	0.000733	0.000781	CcSEcCtD
Gabapentin—Dyspepsia—Pravastatin—atherosclerosis	0.000731	0.000779	CcSEcCtD
Gabapentin—Rash—Rosuvastatin—atherosclerosis	0.00073	0.000779	CcSEcCtD
Gabapentin—Dermatitis—Rosuvastatin—atherosclerosis	0.00073	0.000778	CcSEcCtD
Gabapentin—Urticaria—Simvastatin—atherosclerosis	0.00073	0.000778	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000728	0.000776	CcSEcCtD
Gabapentin—Body temperature increased—Simvastatin—atherosclerosis	0.000726	0.000774	CcSEcCtD
Gabapentin—Abdominal pain—Simvastatin—atherosclerosis	0.000726	0.000774	CcSEcCtD
Gabapentin—Headache—Rosuvastatin—atherosclerosis	0.000726	0.000774	CcSEcCtD
Gabapentin—Hypersensitivity—Lovastatin—atherosclerosis	0.000723	0.000771	CcSEcCtD
Gabapentin—Decreased appetite—Pravastatin—atherosclerosis	0.000722	0.000769	CcSEcCtD
Gabapentin—Pain—Niacin—atherosclerosis	0.000721	0.000769	CcSEcCtD
Gabapentin—Fatigue—Pravastatin—atherosclerosis	0.000716	0.000763	CcSEcCtD
Gabapentin—Pain—Pravastatin—atherosclerosis	0.00071	0.000757	CcSEcCtD
Gabapentin—Constipation—Pravastatin—atherosclerosis	0.00071	0.000757	CcSEcCtD
Gabapentin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000709	0.000756	CcSEcCtD
Gabapentin—Asthenia—Lovastatin—atherosclerosis	0.000704	0.000751	CcSEcCtD
Gabapentin—Pruritus—Lovastatin—atherosclerosis	0.000695	0.00074	CcSEcCtD
Gabapentin—Asthenia—Ezetimibe—atherosclerosis	0.000691	0.000736	CcSEcCtD
Gabapentin—Gastrointestinal pain—Niacin—atherosclerosis	0.00069	0.000735	CcSEcCtD
Gabapentin—Nausea—Rosuvastatin—atherosclerosis	0.000688	0.000733	CcSEcCtD
Gabapentin—Feeling abnormal—Pravastatin—atherosclerosis	0.000684	0.000729	CcSEcCtD
Gabapentin—Pruritus—Ezetimibe—atherosclerosis	0.000681	0.000726	CcSEcCtD
Gabapentin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000679	0.000724	CcSEcCtD
Gabapentin—Hypersensitivity—Simvastatin—atherosclerosis	0.000677	0.000721	CcSEcCtD
Gabapentin—Diarrhoea—Lovastatin—atherosclerosis	0.000672	0.000716	CcSEcCtD
Gabapentin—Urticaria—Niacin—atherosclerosis	0.00067	0.000714	CcSEcCtD
Gabapentin—Abdominal pain—Niacin—atherosclerosis	0.000667	0.000711	CcSEcCtD
Gabapentin—Body temperature increased—Niacin—atherosclerosis	0.000667	0.000711	CcSEcCtD
Gabapentin—Urticaria—Pravastatin—atherosclerosis	0.00066	0.000703	CcSEcCtD
Gabapentin—Asthenia—Simvastatin—atherosclerosis	0.000659	0.000702	CcSEcCtD
Gabapentin—Diarrhoea—Ezetimibe—atherosclerosis	0.000659	0.000702	CcSEcCtD
Gabapentin—Abdominal pain—Pravastatin—atherosclerosis	0.000656	0.0007	CcSEcCtD
Gabapentin—Body temperature increased—Pravastatin—atherosclerosis	0.000656	0.0007	CcSEcCtD
Gabapentin—Pruritus—Simvastatin—atherosclerosis	0.00065	0.000693	CcSEcCtD
Gabapentin—Dizziness—Lovastatin—atherosclerosis	0.000649	0.000692	CcSEcCtD
Gabapentin—Dizziness—Ezetimibe—atherosclerosis	0.000637	0.000679	CcSEcCtD
Gabapentin—Diarrhoea—Simvastatin—atherosclerosis	0.000628	0.00067	CcSEcCtD
Gabapentin—Vomiting—Lovastatin—atherosclerosis	0.000624	0.000665	CcSEcCtD
Gabapentin—Hypersensitivity—Niacin—atherosclerosis	0.000621	0.000662	CcSEcCtD
Gabapentin—Rash—Lovastatin—atherosclerosis	0.000619	0.00066	CcSEcCtD
Gabapentin—Dermatitis—Lovastatin—atherosclerosis	0.000618	0.000659	CcSEcCtD
Gabapentin—Headache—Lovastatin—atherosclerosis	0.000615	0.000656	CcSEcCtD
Gabapentin—Vomiting—Ezetimibe—atherosclerosis	0.000612	0.000653	CcSEcCtD
Gabapentin—Hypersensitivity—Pravastatin—atherosclerosis	0.000612	0.000652	CcSEcCtD
Gabapentin—Dizziness—Simvastatin—atherosclerosis	0.000607	0.000647	CcSEcCtD
Gabapentin—Rash—Ezetimibe—atherosclerosis	0.000607	0.000647	CcSEcCtD
Gabapentin—Dermatitis—Ezetimibe—atherosclerosis	0.000607	0.000647	CcSEcCtD
Gabapentin—Asthenia—Niacin—atherosclerosis	0.000605	0.000645	CcSEcCtD
Gabapentin—Headache—Ezetimibe—atherosclerosis	0.000603	0.000643	CcSEcCtD
Gabapentin—Pruritus—Niacin—atherosclerosis	0.000597	0.000636	CcSEcCtD
Gabapentin—Asthenia—Pravastatin—atherosclerosis	0.000596	0.000635	CcSEcCtD
Gabapentin—Pruritus—Pravastatin—atherosclerosis	0.000587	0.000626	CcSEcCtD
Gabapentin—Vomiting—Simvastatin—atherosclerosis	0.000584	0.000622	CcSEcCtD
Gabapentin—Nausea—Lovastatin—atherosclerosis	0.000583	0.000622	CcSEcCtD
Gabapentin—Rash—Simvastatin—atherosclerosis	0.000579	0.000617	CcSEcCtD
Gabapentin—Dermatitis—Simvastatin—atherosclerosis	0.000578	0.000617	CcSEcCtD
Gabapentin—Diarrhoea—Niacin—atherosclerosis	0.000577	0.000615	CcSEcCtD
Gabapentin—Headache—Simvastatin—atherosclerosis	0.000575	0.000613	CcSEcCtD
Gabapentin—Nausea—Ezetimibe—atherosclerosis	0.000572	0.00061	CcSEcCtD
Gabapentin—Diarrhoea—Pravastatin—atherosclerosis	0.000568	0.000605	CcSEcCtD
Gabapentin—Dizziness—Niacin—atherosclerosis	0.000558	0.000594	CcSEcCtD
Gabapentin—Dizziness—Pravastatin—atherosclerosis	0.000549	0.000585	CcSEcCtD
Gabapentin—Nausea—Simvastatin—atherosclerosis	0.000545	0.000581	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—CNR2—atherosclerosis	0.000545	0.00881	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.000544	0.0088	CbGpPWpGaD
Gabapentin—Vomiting—Niacin—atherosclerosis	0.000536	0.000571	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—PRKCG—atherosclerosis	0.000535	0.00864	CbGpPWpGaD
Gabapentin—Rash—Niacin—atherosclerosis	0.000532	0.000567	CcSEcCtD
Gabapentin—Dermatitis—Niacin—atherosclerosis	0.000531	0.000566	CcSEcCtD
Gabapentin—Headache—Niacin—atherosclerosis	0.000528	0.000563	CcSEcCtD
Gabapentin—Vomiting—Pravastatin—atherosclerosis	0.000528	0.000563	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—F7—atherosclerosis	0.000525	0.00849	CbGpPWpGaD
Gabapentin—Rash—Pravastatin—atherosclerosis	0.000523	0.000558	CcSEcCtD
Gabapentin—Dermatitis—Pravastatin—atherosclerosis	0.000523	0.000557	CcSEcCtD
Gabapentin—BCAT1—Metabolism—ABCG8—atherosclerosis	0.000521	0.00843	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LTA4H—atherosclerosis	0.000521	0.00843	CbGpPWpGaD
Gabapentin—Headache—Pravastatin—atherosclerosis	0.00052	0.000554	CcSEcCtD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.000506	0.00818	CbGpPWpGaD
Gabapentin—Nausea—Niacin—atherosclerosis	0.000501	0.000534	CcSEcCtD
Gabapentin—Nausea—Pravastatin—atherosclerosis	0.000493	0.000526	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.000486	0.00786	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—GHRL—atherosclerosis	0.000468	0.00757	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.000466	0.00754	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000462	0.00747	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.000457	0.00739	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—ADIPOQ—atherosclerosis	0.000453	0.00733	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.000433	0.00701	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CCR2—atherosclerosis	0.000424	0.00685	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL4—atherosclerosis	0.000415	0.00672	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCG1—atherosclerosis	0.000412	0.00666	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.000393	0.00636	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.000393	0.00636	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LDLRAP1—atherosclerosis	0.000387	0.00626	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LCAT—atherosclerosis	0.000387	0.00626	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—FABP4—atherosclerosis	0.000387	0.00626	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOA4—atherosclerosis	0.00038	0.00615	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP7A1—atherosclerosis	0.000374	0.00604	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.000373	0.00603	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—UTS2—atherosclerosis	0.00037	0.00599	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLTP—atherosclerosis	0.000364	0.00589	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—KNG1—atherosclerosis	0.000363	0.00586	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SIRT1—atherosclerosis	0.000357	0.00577	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CX3CR1—atherosclerosis	0.000355	0.00574	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CASR—atherosclerosis	0.000355	0.00574	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—PRKCG—atherosclerosis	0.000354	0.00573	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000348	0.00563	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CYP27A1—atherosclerosis	0.000345	0.00558	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000337	0.00545	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000337	0.00545	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000335	0.00541	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CNR2—atherosclerosis	0.00033	0.00534	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000328	0.00531	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALOX5AP—atherosclerosis	0.000327	0.00529	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALOX15—atherosclerosis	0.000327	0.00529	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PLA2G2A—atherosclerosis	0.000327	0.00529	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOA2—atherosclerosis	0.000327	0.00529	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PRKCG—atherosclerosis	0.000327	0.00528	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—HRH1—atherosclerosis	0.000325	0.00525	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCG5—atherosclerosis	0.000323	0.00523	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCG8—atherosclerosis	0.000316	0.00511	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LTA4H—atherosclerosis	0.000316	0.00511	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPA—atherosclerosis	0.000312	0.00505	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CCL5—atherosclerosis	0.000303	0.0049	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—BGN—atherosclerosis	0.000302	0.00489	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOA5—atherosclerosis	0.000299	0.00484	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARA—atherosclerosis	0.000297	0.0048	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRH1—atherosclerosis	0.000295	0.00477	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000288	0.00466	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PLA2G1B—atherosclerosis	0.000288	0.00466	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000287	0.00463	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL3—atherosclerosis	0.000284	0.00459	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—LEP—atherosclerosis	0.000282	0.00455	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALOX5—atherosclerosis	0.000278	0.0045	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—NOS2—atherosclerosis	0.000262	0.00424	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCR2—atherosclerosis	0.000257	0.00415	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—EDNRA—atherosclerosis	0.000257	0.00415	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—AGT—atherosclerosis	0.000254	0.0041	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GHRL—atherosclerosis	0.00025	0.00404	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCG1—atherosclerosis	0.00025	0.00404	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NAMPT—atherosclerosis	0.00025	0.00404	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LIPC—atherosclerosis	0.000248	0.00401	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOC3—atherosclerosis	0.000247	0.00399	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—atherosclerosis	0.000245	0.00397	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LDLR—atherosclerosis	0.000245	0.00396	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000243	0.00393	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000241	0.0039	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CETP—atherosclerosis	0.000239	0.00387	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FABP4—atherosclerosis	0.000235	0.00379	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LCAT—atherosclerosis	0.000235	0.00379	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA4—atherosclerosis	0.00023	0.00372	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SCARB1—atherosclerosis	0.000229	0.00371	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP7A1—atherosclerosis	0.000226	0.00366	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000221	0.00357	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—KNG1—atherosclerosis	0.00022	0.00355	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AGTR1—atherosclerosis	0.000218	0.00353	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HMGCR—atherosclerosis	0.000216	0.0035	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL4—atherosclerosis	0.000213	0.00345	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—UTS2—atherosclerosis	0.000209	0.00338	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CYP27A1—atherosclerosis	0.000209	0.00338	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000202	0.00326	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CASR—atherosclerosis	0.000201	0.00324	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALOX15—atherosclerosis	0.000198	0.00321	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALOX5AP—atherosclerosis	0.000198	0.00321	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLA2G2A—atherosclerosis	0.000198	0.00321	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA2—atherosclerosis	0.000198	0.00321	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCG5—atherosclerosis	0.000196	0.00317	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ABCA1—atherosclerosis	0.000193	0.00312	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—UTS2—atherosclerosis	0.00019	0.00307	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPA—atherosclerosis	0.000189	0.00306	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CNR2—atherosclerosis	0.000187	0.00302	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000186	0.00301	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—EDN1—atherosclerosis	0.000185	0.00299	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL5—atherosclerosis	0.000184	0.00297	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—BGN—atherosclerosis	0.000183	0.00296	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CX3CR1—atherosclerosis	0.000182	0.00295	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CASR—atherosclerosis	0.000182	0.00295	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA5—atherosclerosis	0.000181	0.00293	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000179	0.00289	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLA2G1B—atherosclerosis	0.000175	0.00282	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRH1—atherosclerosis	0.000174	0.00282	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CNR2—atherosclerosis	0.000169	0.00274	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALOX5—atherosclerosis	0.000169	0.00273	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000166	0.00269	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—HMOX1—atherosclerosis	0.000166	0.00268	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL8—atherosclerosis	0.000165	0.00267	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—MAPK8—atherosclerosis	0.000165	0.00266	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOB—atherosclerosis	0.000159	0.00256	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTM1—atherosclerosis	0.000154	0.00249	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AGT—atherosclerosis	0.000154	0.00248	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—LPL—atherosclerosis	0.000151	0.00245	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NAMPT—atherosclerosis	0.000151	0.00245	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LIPC—atherosclerosis	0.00015	0.00243	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOC3—atherosclerosis	0.000149	0.00241	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LDLR—atherosclerosis	0.000148	0.0024	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GPX1—atherosclerosis	0.000148	0.00239	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL3—atherosclerosis	0.000146	0.00235	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000145	0.00235	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCR2—atherosclerosis	0.000145	0.00235	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CETP—atherosclerosis	0.000145	0.00234	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CD36—atherosclerosis	0.000144	0.00233	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—F2—atherosclerosis	0.000142	0.00229	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GHRL—atherosclerosis	0.000141	0.00229	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—SCARB1—atherosclerosis	0.000139	0.00224	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA4—atherosclerosis	0.000137	0.00221	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—MTHFR—atherosclerosis	0.000136	0.0022	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARA—atherosclerosis	0.000134	0.00216	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCR2—atherosclerosis	0.000132	0.00213	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDNRA—atherosclerosis	0.000132	0.00213	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000131	0.00212	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMGCR—atherosclerosis	0.000131	0.00212	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AGT—atherosclerosis	0.00013	0.00209	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GHRL—atherosclerosis	0.000128	0.00208	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOE—atherosclerosis	0.000127	0.00205	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCL2—atherosclerosis	0.000126	0.00204	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL4—atherosclerosis	0.000126	0.00204	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CAV1—atherosclerosis	0.000126	0.00203	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOA1—atherosclerosis	0.000125	0.00203	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—KNG1—atherosclerosis	0.000124	0.00201	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000123	0.00199	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA2—atherosclerosis	0.000118	0.0019	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ABCA1—atherosclerosis	0.000117	0.00189	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CG—atherosclerosis	0.000115	0.00185	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KNG1—atherosclerosis	0.000113	0.00182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—UTS2—atherosclerosis	0.000112	0.00181	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGTR1—atherosclerosis	0.000112	0.00181	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PPARG—atherosclerosis	0.000111	0.00179	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—INS—atherosclerosis	0.000108	0.00175	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CX3CR1—atherosclerosis	0.000108	0.00174	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASR—atherosclerosis	0.000108	0.00174	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CX3CL1—atherosclerosis	0.000106	0.00171	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—IL6—atherosclerosis	0.000105	0.0017	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—EDN1—atherosclerosis	0.000105	0.00169	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCL5—atherosclerosis	0.000104	0.00168	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—HMOX1—atherosclerosis	0.0001	0.00162	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CNR2—atherosclerosis	0.0001	0.00162	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—atherosclerosis	0.0001	0.00162	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MMP3—atherosclerosis	9.98e-05	0.00161	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ALB—atherosclerosis	9.94e-05	0.00161	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PRKCG—atherosclerosis	9.86e-05	0.00159	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOB—atherosclerosis	9.61e-05	0.00155	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—NOS3—atherosclerosis	9.51e-05	0.00154	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EDN1—atherosclerosis	9.5e-05	0.00154	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL5—atherosclerosis	9.42e-05	0.00152	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTM1—atherosclerosis	9.34e-05	0.00151	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—LPL—atherosclerosis	9.17e-05	0.00148	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRKCG—atherosclerosis	8.96e-05	0.00145	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GPX1—atherosclerosis	8.95e-05	0.00145	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VWF—atherosclerosis	8.92e-05	0.00144	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOC3—atherosclerosis	8.86e-05	0.00143	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LDLR—atherosclerosis	8.81e-05	0.00142	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CD36—atherosclerosis	8.71e-05	0.00141	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—atherosclerosis	8.69e-05	0.00141	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AGT—atherosclerosis	8.68e-05	0.0014	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL3—atherosclerosis	8.6e-05	0.00139	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—MTHFR—atherosclerosis	8.26e-05	0.00134	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NCF1—atherosclerosis	8.24e-05	0.00133	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARA—atherosclerosis	8.1e-05	0.00131	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—F2—atherosclerosis	8.02e-05	0.0013	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AGT—atherosclerosis	7.88e-05	0.00127	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AGT—atherosclerosis	7.85e-05	0.00127	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCR2—atherosclerosis	7.78e-05	0.00126	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDNRA—atherosclerosis	7.78e-05	0.00126	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CYBA—atherosclerosis	7.75e-05	0.00125	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—atherosclerosis	7.69e-05	0.00124	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—atherosclerosis	7.67e-05	0.00124	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CAV1—atherosclerosis	7.62e-05	0.00123	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOA1—atherosclerosis	7.6e-05	0.00123	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PARP1—atherosclerosis	7.58e-05	0.00123	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GHRL—atherosclerosis	7.58e-05	0.00123	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLAT—atherosclerosis	7.58e-05	0.00123	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—F2—atherosclerosis	7.28e-05	0.00118	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—atherosclerosis	6.97e-05	0.00113	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—atherosclerosis	6.94e-05	0.00112	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—atherosclerosis	6.7e-05	0.00108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KNG1—atherosclerosis	6.66e-05	0.00108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGTR1—atherosclerosis	6.62e-05	0.00107	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—INS—atherosclerosis	6.57e-05	0.00106	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCL2—atherosclerosis	6.49e-05	0.00105	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLG—atherosclerosis	6.45e-05	0.00104	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SOCS3—atherosclerosis	6.11e-05	0.000987	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ALB—atherosclerosis	6.02e-05	0.000973	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP3—atherosclerosis	5.9e-05	0.000953	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF2—atherosclerosis	5.87e-05	0.000949	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—NOS3—atherosclerosis	5.76e-05	0.000931	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOB—atherosclerosis	5.7e-05	0.000921	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—atherosclerosis	5.65e-05	0.000914	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EDN1—atherosclerosis	5.61e-05	0.000907	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL5—atherosclerosis	5.57e-05	0.0009	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LPL—atherosclerosis	5.44e-05	0.00088	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PRKCG—atherosclerosis	5.29e-05	0.000856	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—atherosclerosis	5.27e-05	0.000852	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SPP1—atherosclerosis	5.15e-05	0.000833	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—atherosclerosis	5.13e-05	0.00083	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PDGFB—atherosclerosis	4.77e-05	0.000771	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGT—atherosclerosis	4.66e-05	0.000753	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—LEP—atherosclerosis	4.56e-05	0.000738	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—atherosclerosis	4.56e-05	0.000738	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CAV1—atherosclerosis	4.52e-05	0.000731	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOA1—atherosclerosis	4.51e-05	0.000729	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—atherosclerosis	4.37e-05	0.000706	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ESR1—atherosclerosis	4.36e-05	0.000704	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—F2—atherosclerosis	4.3e-05	0.000696	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—atherosclerosis	4.12e-05	0.000666	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—MAPK3—atherosclerosis	3.94e-05	0.000637	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—INS—atherosclerosis	3.9e-05	0.00063	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCL2—atherosclerosis	3.83e-05	0.00062	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—atherosclerosis	3.77e-05	0.000609	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SERPINE1—atherosclerosis	3.58e-05	0.000579	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOS3—atherosclerosis	3.42e-05	0.000553	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—atherosclerosis	3.03e-05	0.00049	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—atherosclerosis	2.93e-05	0.000473	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—IL6—atherosclerosis	2.88e-05	0.000466	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—atherosclerosis	2.74e-05	0.000443	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NFKB1—atherosclerosis	2.71e-05	0.000439	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK8—atherosclerosis	2.67e-05	0.000431	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—atherosclerosis	2.66e-05	0.00043	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—atherosclerosis	2.65e-05	0.000428	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—atherosclerosis	2.46e-05	0.000398	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—atherosclerosis	2.44e-05	0.000394	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MAPK3—atherosclerosis	2.33e-05	0.000377	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—atherosclerosis	2.26e-05	0.000365	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IL6—atherosclerosis	1.7e-05	0.000275	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—atherosclerosis	1.57e-05	0.000254	CbGpPWpGaD
